2014 CME Symposia - Breakfast Symposium A
Register for the CMHC today to sign up for these value-added CME/CE activities-at no additional cost!
Pre-registration for symposia will open at the end of August for CMHC registrants to make selections. There are no additional fees to attend. Symposia include meals or refreshments and seating is limited and on a first-come, first-serve basis.
Breakfast Symposium A
Friday · 6:15 - 7:45am
Optimizing Antihypertensive Therapies in High-Risk and Difficult-to-Treat Patients with Hypertension
Supported by an educational grant from Forest Laboratories, Inc.
Despite well-established risks, hypertension remains under-treated and, when treated, often stubbornly difficult to control. This symposium seeks to improve guideline adherence and help clinicians integrate antihypertensive therapies into the management of high-risk patient populations including the elderly (those 65 and older), African Americans, patients suffering from heart failure, the obese, and individuals with diabetes and/or the metabolic syndrome. Case-based clinical scenarios and a panel discussion will clarify how best to integrate effective therapies into the management of patients with hypertension to reduce global cardiometabolic risk and improve clinical outcomes.
- Recognize the clinical relevance of how altered nitric oxide balance may contribute to the progression of hypertension.
- Compare and contrast recommended antihypertensive therapies in terms of blood pressure control, side effects, and impact on global cardiometabolic risk factors.
- Evaluate the clinical trial data of various antihypertensive therapies when used in combination to manage high-risk and difficult-to-treat patients with hypertension.
- Integrate strategies to implement current guideline recommendations for antihypertensive therapies, including recommendations for patients with compelling indications who may need aggressive therapy.
Preliminary Agenda & Faculty
|6:15 - 6:20 am
||Chairperson: George L. Bakris, MD
|6:20 - 6:35 am
||Hypertension Guidelines Update: Current Controversies and Clinical Implications
||Presenter: Michael A. Weber, MD
|6:35 - 6:55 am
||Pharmacology of Beta Blockers and the Role of Nitric Oxide in Vasodilation
||Presenter: Keith C. Ferdinand, MD
|6:55 - 7:15 am
||Combination Antihypertensive Therapy: Today's Options, Tomorrow's Possibilities
||Presenter: George L. Bakris, MD
|7:15 - 7:35 am
||Complex Cases in Hypertension: Optimizing Antihypertensive Therapy in Difficult-to-Treat Patients
||Presenter: Thomas Giles, MD
|7:35 - 7:45 am
||Moderator: George L. Bakris, MD
Discussants: Michael A. Weber, MD; Keith C. Ferdinand, MD; Thomas Giles, MD
Keith C. Ferdinand, MD, FACC, FAHA
Professor of Medicine
Tulane University School of Medicine
Tulane Heart and Vascular Institute
New Orleans, LA
Thomas D. Giles, MD
- Heart and Vascular Institute
- Tulane University School of Medicine
Michael A. Weber, MD
- Professor of Medicine
- State University of New York Downstate College of Medicine
George L. Bakris, MD
Professor of Medicine
Director, ASH Comprehensive Hypertension Center
University of Chicago Medicine
View Complete Accreditation Details and Program Overview: CMHC Accreditation